Ibogaine vs. Suboxone
Two fundamentally different approaches to opioid addiction recovery — understanding the differences to make an informed choice.
Ibogaine
- • Single treatment (12-24 hours)
- • Aims to reset addiction at neurological root
- • No ongoing opioid receptor activation
- • Noribogaine provides weeks-months of craving reduction
- • Requires travel to Mexico
- • Not FDA-approved (growing research base)
- • Cost: $8,000-$12,500 one-time
- • Carries cardiac risks requiring medical monitoring
Suboxone (Buprenorphine/Naloxone)
- • Daily medication (potentially long-term or lifelong)
- • Manages withdrawal and cravings through partial opioid activation
- • Maintains low-level opioid receptor dependency
- • Effective as long as medication is taken
- • Available by prescription in the US
- • FDA-approved with decades of clinical data
- • Cost: $100-$500/month ongoing
- • Generally well-tolerated side effect profile
The Bottom Line
Neither approach is universally better. Suboxone has saved countless lives and is the right choice for many people — it's accessible, well-studied, and effective at stabilizing lives. Ibogaine may be more appropriate for those who want to be completely free of opioid medications, who haven't succeeded with medication-assisted treatment, or who are seeking a fundamentally different approach. The best choice depends on your individual situation, and ideally should be made with guidance from a healthcare provider who understands both options.
The Ibogaine Briefing
Stay informed — get the latest ibogaine research, news, and stories delivered to your inbox.
We respect your privacy. Unsubscribe anytime.
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Ibogaine treatment carries serious risks including cardiac complications. Always consult a qualified healthcare provider before pursuing any treatment.